ALXO
ALX Oncology Holdings Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
ALX Oncology Holdings Inc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
ALX Oncology Holdings Inc
1.24
No thesis.
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | RA Capital ManagementRA Capital Management | $26.9M | 12.36% | 0.00% | |
| 2 | venBio PartnersvenBio Partners | $26.7M | 12.23% | 0.00% | |
| 3 | BlackRockBlackRockindex-like | $15.3M | 7.03% | +1552.42% | |
| 4 | Redmile GroupRedmile | $15.3M | 7.02% | −7.18% | |
| 5 | Blackstone GroupBlackstone | $13.6M | 6.26% | +13.16% | |
| 6 | Driehaus Capital ManagementDriehaus | $12.5M | 5.72% | +5.07% | |
| 7 | Silverarc Capital ManagementSilverarc | $11.9M | 5.45% | new | |
| 8 | TCG Crossover ManagementTCG Crossover | $11.7M | 5.37% | −56.54% | |
| 9 | Vanguard Capital ManagementVanguardindex-like | $10.3M | 4.72% | +18.99% | |
| 10 | Vivo CapitalVivo Capital | $6.6M | 3.02% | 0.00% | |
| 11 | Marshall WaceMarshall Wace | $6.4M | 2.92% | −18.25% | |
| 12 | 5AM Venture Management5AM Venture | $6.3M | 2.90% | 0.00% | |
| 13 | Almitas CapitalAlmitas Capital | $6.1M | 2.79% | −7.42% | |
| 14 | Orbimed AdvisorsOrbimed | $5.9M | 2.72% | 0.00% | |
| 15 | Geode Capital ManagementGeodeindex-like | $5.8M | 2.65% | +464.98% | |
| 16 | Two Sigma InvestmentsTwo Sigma | $4.5M | 2.07% | +37.18% | |
| 17 | Millennium ManagementMillennium | $3.2M | 1.47% | −22.38% | |
| 18 | State StreetState Streetindex-like | $3.1M | 1.42% | +752.48% | |
| 19 | Acadian Asset ManagementAcadian | $2.7M | 1.25% | +19.30% | |
| 20 | JPMorgan ChaseJPMorgan Chase | $2.3M | 1.05% | +1055180.81% | |
| 21 | Northern TrustNorthern Trustindex-like | $1.9M | 0.89% | +583.15% | |
| 22 | Ensign Peak AdvisorsEnsign Peak | $1.7M | 0.77% | −14.75% | |
| 23 | Nantahala Capital ManagementNantahala | $1.6M | 0.71% | new | |
| 24 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $1.6M | 0.71% | +665.45% | |
| 25 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $1.5M | 0.71% | +152.48% |
94 managers report $218.0M of ALX Oncology on form 13F for the quarter ended Jun 30 '26. 14 of them hold 80% of it; RA Capital Management is largest at 12.36%.
Linked news
Expected move
No implied move.
No implied move.
No implied move.